Yiming Chen, Hagop Kantarjian, Haijun Wang, Jorge Cortes and Farhad Ravandi Acute promyelocytic leukemia: A population-based study on incidence and survival in the United States, 1975-2008 Cancer 118
Version of Record online: 15 JUN 2012 | DOI: 10.1002/cncr.27623
The outcome of patients with acute promyelocytic leukemia has improved significantly during the past 2 decades due to introduction of all-trans retinoic acid and arsenic trioxide, 2 agents that are targeted at the pathogenic molecular aberration responsible for the disease.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field